Finding the root cause of bronchiolitis symptoms

January 25, 2018, Children's National Medical Center
Robert J. Freishtat, M.D., M.P.H., chief of emergency medicine at Children's National Health System. Credit: Children's National Health System

Every winter, doctors' offices and hospital emergency rooms fill with children who have bronchiolitis, an inflammation of the small airways in the lung. It's responsible for about 130,000 admissions each year. Sometimes these young patients have symptoms reminiscent of a bad cold with a fever, cough and runny nose. Other times, bronchiolitis causes breathing troubles so severe that these children end up in the intensive care unit.

"The reality is that we don't have anything to treat these patients aside from supportive care, such as intravenous fluids or respiratory support," says Robert J. Freishtat, M.D., M.P.H., chief of emergency medicine at Children's National Health System. "That's really unacceptable because some kids get very, very sick."

Several years ago, Dr. Freishtat says a clinical trial tested using steroids as a potential treatment for bronchiolitis. The thinking was that these drugs might reduce the inflammation that's a hallmark of this condition. However, he says, the results weren't a slam-dunk for steroids: The drugs didn't seem to improve outcomes any better than a placebo.

But the trial had a critical flaw, he explains. Rather than having one homogenous cause, bronchiolitis is an umbrella term for a set of symptoms that can be caused by a number of different viruses. The most common ones are respiratory syncytial virus (RSV) and rhinovirus, the latter itself being an assortment of more than 100 different but related viruses. By treating bronchiolitis as a single disease, Dr. Freishtat says researchers might be ignoring the subtleties of each virus that influence whether a particular medication is useful.

"By treating all bronchiolitis patients with a single agent, we could be comparing apples with oranges," he says. "The treatment may be completely different depending on the underlying cause."

To test this idea, Dr. Freishtat and colleagues examined nasal secretions from 32 infants who had been hospitalized with bronchiolitis from 2011 to 2014 at 17 medical centers across the country that participate in a consortium called the 35th Multicenter Airway Research Collaboration. In half of these patients, lab tests confirmed that their bronchiolitis was caused by RSV; in the other half, the cause was rhinovirus.

From these nasal secretions, the researchers extracted nucleic acids called microRNAs. These molecules regulate the effects of different genes through a variety of different mechanisms, usually resulting in the effects of target genes being silenced. A single microRNA typically targets multiple genes by affecting messenger RNA, a molecule that's key for producing proteins.

Comparing results between patients with RSV or rhinovirus, the researchers found 386 microRNAs that differed in concentration. Using bioinformatic software, they traced these microRNAs to thousands of messenger RNAs, looking for any interesting clues to important mechanisms of illness that might vary between the two viruses.

Their findings eventually turned up important differences between the two viruses in the NFkB (nuclear factor kappa-light-chain-enhancer of activated B cells) pathway, a protein cascade that's intimately involved in the inflammatory response and is a target for many types of steroids. Rhinovirus appears to upregulate the expression of many members of this protein family, driving cells to make more of them, and downregulate inhibitors of this cascade. On the other hand, RSV didn't seem to have much of an effect on this critical pathway.

To see if these effects translated into cells making more inflammatory molecules in this pathway, the researchers searched for various members of this protein cascade in the . They found an increase in two, known as RelA and NFkB2.

Based on these findings, published online Jan. 17, 2018, in Pediatric Research, steroids might work for rhinovirus but not for RSV, notes Dr. Freishtat the study's senior author.

"We're pretty close to saying that you'd need to conduct a clinical trial with respect to the , rather than the symptoms, to measure any effect from a given drug," he says.

Future might test the arsenal of currently available medicines to see if any has an effect on caused by either of these two viruses. Further research into the mechanisms of each type of illness also might turn up new targets that researchers could develop new medicines to hit.

"Instead of determining the disease based on symptoms," he says, "we can eventually treat the root cause."

Explore further: Study finds bronchiolitis severity depends on the virus, and questions the practice of rooming children together

More information: Kohei Hasegawa et al, RSV vs. rhinovirus bronchiolitis: difference in nasal airway microRNA profiles and NFκB signaling, Pediatric Research (2017). DOI: 10.1038/pr.2017.309

Related Stories

Study finds bronchiolitis severity depends on the virus, and questions the practice of rooming children together

April 4, 2012
A 16-hospital study, led by researchers at  Boston Children’s Hospital and Massachusetts General Hospital, is challenging common wisdom about bronchiolitis, a respiratory illness and the leading cause of hospitalization ...

'Tis the season for respiratory virus

December 20, 2017
There may be something in the air this holiday season, and it's not snow. It's something much less festive – respiratory syncytial virus, or RSV. Baylor College of Medicine expert Dr. Pedro A. Piedra breaks down the dangers ...

Practice variation in treatment for bronchiolitis in infants

November 28, 2017
(HealthDay)—For infants with bronchiolitis, the use of evidence-based supportive therapies (EBSTs) varies by hospital site, according to a study published online Nov. 28 in Pediatrics.

Treatment strategy may reduce infants' wheezing caused by virus

November 19, 2014
(Medical Xpress)—The antibiotic azithromycin may reduce the risk of recurrent wheezing in infants hospitalized with a common respiratory infection, according to a small pilot study at Washington University School of Medicine ...

Past exposures shape immune response in pediatric acute respiratory infections

January 12, 2018
Acute respiratory tract infections (ARTI) are the leading global cause of death in early childhood, according to the Centers for Disease Control and Prevention (CDC). Lower respiratory tract infections, including bronchiolitis ...

AAP updates guidelines for bronchiolitis in infants

October 27, 2014
(HealthDay)—A new clinical practice guideline that offers physicians guidance for the diagnosis and management of infants with bronchiolitis was published online Oct. 27 in Pediatrics.

Recommended for you

The effects of happiness and sadness on children's snack consumption

February 19, 2018
A University of Texas at Dallas psychologist has examined the preconceptions about the effects of emotions on children's eating habits, creating the framework for future studies of how dietary patterns evolve in early childhood.

Cycle of infant reflux signals a call to help mothers

February 14, 2018
Western Sydney University research has found that first-time mothers with mental health issues – in particular, maternal anxiety – are five times as likely to have their baby noted as having reflux when admitted to hospital.

Safe-sleep recommendations for infants have not reduced sudden deaths in newborns

February 14, 2018
An analysis of trends in sudden unexpected infant death (SUID) over the past two decades finds that the drop in such deaths that took place following release of the 1992 American Academy of Pediatrics (AAP) "back to sleep" ...

Most children with sickle cell anemia not receiving key medication to stay healthy

February 13, 2018
One of the greatest health threats to children with sickle cell anemia is getting a dangerous bacterial infection—but most are not receiving a key medication to reduce the risk, a new study suggests.

Premature babies' low blood pressure puzzle explained

February 13, 2018
Scientists have discovered crucial new information about how a foetus develops which could explain why very premature babies suffer low blood pressure and other health problems.

Babies face higher SIDS risk in certain states

February 12, 2018
(HealthDay)—Sudden infant death syndrome (SIDS) claims the lives of some 3,500 babies in the United States each year, but its toll is far heavier in some states than others, health officials report.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.